Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study

Background Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal mo...

Full description

Saved in:

Bibliographic Details
Published in:	BMC neurology Vol. 21; no. 1; pp. 1 - 15
Main Authors:	Liebert, Ann, Bicknell, Brian, Laakso, E-Liisa, Heller, Gillian, Jalilitabaei, Parastoo, Tilley, Sharon, Mitrofanis, John, Kiat, Hosen
Format:	Journal Article
Language:	English
Published:	London BioMed Central 02.07.2021 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Aging Alzheimer's disease Animal models Brain research Care and treatment Clinical trials Cognition COVID-19 Dopamine receptors Ethics Laser therapy Lasers Light therapy Medicine Medicine & Public Health Mobility Motor skill Motor symptoms Movement disorders Neurochemistry Neurodegenerative diseases Neurology Neurosurgery Parkinson's disease Photobiomodulation Phototherapy Placebos Testing Therapy Australia Mobility Cognition Parkinson’s disease Photobiomodulation Motor symptoms
ISSN:	1471-2377, 1471-2377
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!